In vivo probe-based confocal laser endomicroscopy in amiodarone-related pneumonia

European Respiratory Journal

Volumn 42, Issue 6, 2013, Pages 1646-1658

  Salaün, Mathieu ^a,b   Roussel, Francis ^c   Bourg Heckly, Geneviève ^d   Vever Bizet, Christine ^d   Dominique, Stéphane ^a   Genevois, Anne ^c   Jounieaux, Vincent ^e   Zalcman, Gérard ^f   Bergot, Emmanuel ^f   Vergnon, Jean Michel ^g   Thiberville, Luc ^a,b  

^a HÔPITAL CHARLES NICOLLE   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d CNRS   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f CAEN UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ JEAN MONNET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CELL SIZE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG SAFETY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; MALE; MOLECULAR PROBE; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPECTROMETRY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMIODARONE; BRONCHOALVEOLAR LAVAGE; BRONCHOSCOPY; FEMALE; FLUORESCENT DYES; HUMANS; LASERS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MICROSCOPY, CONFOCAL; OBSERVER VARIATION; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; VASODILATOR AGENTS;

EID: 84884469357     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00191911     Document Type: Article

References (26)

1. Connolly SJ. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999; 100: 2025-2034.
2. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007; 298: 1312-1322.
3. Rakita L, Sobol SM, Mostow N, et al. Amiodarone pulmonary toxicity. Am Heart J 1983; 106: 906-916.
4. Rotmensch HH, Liron M, Tupilski M, et al. Possible association of pneumonitis with amiodarone therapy. Am Heart J 1980; 100: 412-413.
5. Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 2001; 120: 275-282.
6. Brinker A, Johnston M. Acute pulmonary injury in association with amiodarone. Chest 2004; 125: 1591-1592.
7. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990; 82: 51-59.
8. Greenspon AJ, Kidwell GA, Hurley W, et al. Amiodarone-related postoperative adult respiratory distress syndrome. Circulation 1991; 84: Suppl., III407-III415.
9. Wood DL, Osborn MJ, Rooke J, et al. Amiodarone pulmonary toxicity: report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin Proc 1985; 60: 601-603.
10. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone trials meta-analysis investigators. Lancet 1997; 350: 1417-1424.
11. Singh SN, Fisher SG, Deedwania PC, et al. Pulmonary effect of amiodarone in patients with heart failure. The congestive heart failure-survival trial of antiarrhythmic therapy (CHF-STAT) investigators (veterans affairs cooperative study no. 320). J Am Coll Cardiol 1997; 30: 514-517.
12. Roca J, Heras M, Rodriguez-Roisin R, et al. Pulmonary complications after long term amiodarone treatment. Thorax 1992; 47: 372-376.
13. Martin WJ 2nd, Osborn MJ, Douglas WW. Amiodarone pulmonary toxicity. Assessment by bronchoalveolar lavage. Chest 1985; 88: 630-631.
14. Bedrossian CW, Warren CJ, Ohar J, et al. Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry. Ann Diagn Pathol 1997; 1: 47-56.
15. Thiberville L, Moreno-Swirc S, Vercauteren T, et al. In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy. Am J Respir Crit Care Med 2007; 175: 22-31.
16. Thiberville L, Salaün M, Lachkar S, et al. Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J 2009; 33: 974-985.
17. Thiberville L, Salaün M, Lachkar S, et al. Confocal fluorescence endomicroscopy of the human airways. Proc Am Thorac Soc 2009; 6: 444-449.
18. Newton R, Kemp S, Zoumot Z, et al. An unusual case of haemoptysis. Thorax 2010; 65: 309.
19. Mercer RR, Crapo JD. Spatial distribution of collagen and elastin fibers in the lungs. J Appl Physiol 1990; 69: 756-765.
20. Weibel ER, Sapoval B, Filoche M. Design of peripheral airways for efficient gas exchange. Respir Physiol Neurobiol 2005; 148: 3-21.
21. Désir C, Petitjean C, Heutte L, et al. Using a priori knowledge to classify in vivo images of the lung. Lect Notes Comp Sci 2010; 6216: 207-212.
22. Thiberville L, Salaün M, Bourg-Heckly G. In vivo confocal microendoscopy: from the proximal bronchus down to the pulmonary acinus. In: Strausz J, Bolliger CT, eds. Interventional Pulmonology. Eur Respir Monogr 2010; 48: 73-89.
23. Kahn FW, Jones JM, England DM. Diagnosis of pulmonary hemorrhage in the immunocompromised host. Am Rev Respir Dis 1987; 136: 155-160.
24. Camus P. Drug-induced infiltrative lung diseases. In: Schwarz MI, King T, eds. Infiltrative Lung Diseases. 4th Edn. Hamilton, BC Decker, Inc., 2003; pp. 485-534.
25. Keller CA, Erasmus D, Alvarez F, et al. Preliminary observations in the use of confocal alveolar endomicroscopy in recipients of single lung transplantation. Am J Respir Crit Care Med 2010; 181: A4316.
26. Trello CA, Williams DA, Keller CA, et al. Increased gelatinolytic activity in bronchoalveolar lavage fluid in stable lung transplant recipients. Am J Respir Crit Care Med 1997; 156: 1978-1986.